Canaccord upgraded the TP to$0.85 this morning with their 4th (!!!) FY17 EBITDA upgrade.
"BUY recommendation retained, however our price target is marginally increased to A$0.85ps (previously A$0.80ps). In our view, RXP's valuation remains appealing as an emerging growth stock. The company exhibits the fastest organic revenue growth profile of its listed peers, despite trading at material discount (-50%, FY17 EV/EBIT: ASZ 10.2x, UXC 11.1x, OKN 15.7x [acquired by Dimension Data])."
Add to My Watchlist
What is My Watchlist?